Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) — Cash Flow Quality Index
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) has a Cash Flow Quality Index of 10.86x as of June 2023. Operating cash flow of $118.87 Million exceeds net income of $10.94 Million, indicating high earnings quality where cash backs reported profits. Explore Shanghai Shenqi Pharmaceutical Investmen operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check how aggressively does Shanghai Shenqi Pharmaceutical Investmen reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (2015–2024)
Year-by-year earnings quality comparison for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B. For live market cap and the full company financial profile, see market cap of Shanghai Shenqi Pharmaceutical Investmen.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.91x | $207.79 Million | $71.39 Million | ▼ -23.0% |
| 2023 | 3.78x | $215.59 Million | $57.00 Million | ▼ -42.6% |
| 2022 | 6.59x | $319.23 Million | $48.48 Million | ▲ +148.8% |
| 2021 | 2.65x | $184.26 Million | $69.62 Million | ▲ +73.3% |
| 2019 | 1.53x | $128.28 Million | $83.97 Million | ▲ +9.1% |
| 2018 | 1.40x | $148.53 Million | $106.09 Million | ▲ +170.9% |
| 2017 | 0.52x | $66.99 Million | $129.60 Million | ▲ +16397.2% |
| 2016 | 0.00x | $570.41K | $182.06 Million | ▼ -97.7% |
| 2015 | 0.14x | $30.12 Million | $216.73 Million | — |